FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine Booster For Children Ages Five To 11

The New York Times (5/17, LaFraniere) reports that the FDA “authorized booster shots of the Pfizer-BioNTech vaccine on Tuesday for children 5 to 11, the latest in a series of actions intended to bolster waning protection against infection from the coronav...